New Post has been published on Stock Markets Daily
New Post has been published on http://www.stockmarketsdaily.com/small-cap-rxi-pharmaceuticals-corporation-nasdaqrxii/11214/
Small Cap Buy: RXi Pharmaceuticals (NASDAQ:RXII)
(adsbygoogle = window.adsbygoogle || []).push();
RXi Pharmaceuticals Corporation (NASDAQ:RXII) is a micro-cap biotech company making waves in the market so it seems with increased trading volumes in the last few days. As such, we have a look at what the analysts of RXII believe the longer term outlook and their subsequent ratings for the stock are. [Trend Analysis]
RXi Pharmaceuticals Corporation (NASDAQ:RXII) last traded at $1.30 after moving down -13.33% for the trading day. The company last released their quarterly earnings results on November 13th for the period ended Sep-14. The company reported earnings of -$0.17.
The current average broker recommendation for RXi Pharmaceuticals Corporation, according to Zack’s research, is 1.00, based on 2 broker ratings. With 1 being a strong buy and 5 being a strong sell, this means that on a consensus basis, analysts currently see RXi Pharmaceuticals Corporation as a strong buy. The 12 month target consensus price estimate among these analysts for RXi Pharmaceuticals Corporation is currently at $9.00.
Out of the 2 broker recommendations for RXII, 2 recommend it as a strong buy, 0 as a buy, 0 as a hold 0 as a sell and 0 as a strong sell.
For the current quarter, the consensus analyst estimate for RXi Pharmaceuticals Corporation (NASDAQ:RXII) is -$0.14, with analysts expecting year on year growth for the company of 61.11%
About RXi Pharmaceuticals Corporation (NASDAQ:RXII)
RXi Pharmaceuticals Corporation is a biotechnology company focused on discovering, developing and commercializing therapies based on its RNAi platform. The Company is developing RXI-109, which is used for the reduction of dermal scarring in planned surgeries, as well as reduces the expression of connective tissue growth factor. RXi Pharmaceuticals Corporation is based in Worcester, Massachusetts.